Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands
Research Ethics
Health Services Research
Human research
Health administration
DOI:
10.1186/s12961-019-0520-4
Publication Date:
2020-01-28T09:03:41Z
AUTHORS (5)
ABSTRACT
Abstract Background Disproportionate regulation of health and medical research contributes to waste. Better understanding exemptions from ethics review in different jurisdictions may help guide modification processes reduce Our aim was identify examples low-risk human exempt reviews Australia, the United Kingdom, States Netherlands. Methods We examined documents providing national guidance on each country, including those authored by National Health Medical Research Council (Australia), Service (United Kingdom), Office for Human Protections States) Central Committee Involving Humans (the Netherlands). Examples types projects were identified, similar grouped together. Results Nine categories across four countries; these existing data or specimen, questionnaire survey, interview, post-marketing study, evaluation public benefit service programme, randomised controlled trials, with staff their professional role, audit evaluation, other exemptions. Existing non-identifiable specimens all countries. Four – exempted one country each. The remaining two three Conclusions varied considerably. Given considerable costs burdens researchers committees, it would be worthwhile develop provide clearer exemptions, illustrated examples, transparent underpinning rationales.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....